General description
An internal standard suitable for GC/MS or LC/MS applications with chlordiazepoxide or demoxepam such as toxicology analysis, forensic testing, pain prescription monitoring, or isotope dilution methods. Demoxepam is a benzodiazepine drug and anticonvulsant as well as a primary metabolite of chlordiazepoxide, marketed as Klopoxid or Librax® for the treatment of anxiety and muscle spasms or pain.
Legal Information
CERILLIANT is a registered trademark of Cerilliant Corporation
Librax is a registered trademark of Valeant Pharmaceuticals North America LLC
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Cerilliant Corporation
Molecular Weight: 291.74. Empirical Formula: C15D5H6ClN2O2. grade: certified reference material. Quality Level: 300. form: liquid. feature: Snap-N-Spike®. /Snap-N-Shoot®. . packaging: ampule of 1 . mL. manufacturer/tradename: Cerilliant®. . drug control: Narcotic Licence Schedule B (Switzerland). concentration: 100 . μ. g/mL in acetonitrile. technique(s): gas chromatography (GC): suitable, liquid chromatography (LC): suitable. application(s): clinical testing. format: single component solution. storage temp.: −. 20°C. SMILES string: [2H]c1c([2H])c([2H])c(c([2H])c1[2H])C2: [N+]([O-])CC(: O)Nc3ccc(Cl)cc23. InChI: 1S/C15H11ClN2O2/c16-11-6-7-13-12(8-11)15(10-4-2-1-3-5-10)18(20)9-14(19)17-13/h1-8H,9H2,(H,17,19)/i1D,2D,3D,4D,5D. InChI key: GGRWZBVSUZZMKS-RALIUCGRSA-N. Pictograms: GHS02,GHS07. Signal Word: Danger. Hazard Statements: H225 - H302 + H312 + H332 - H319. Precautionary Statements: P210 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P312 - P305 + P351 + P338. Hazard Classifications: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2. Storage Class Code: 3 - Flammable liquids. WGK: WGK 2. Flash Point(F): 35.6 °F - closed cup. Flash Point(C): 2 °C - closed cup.- UPC:
- 12191601
- Condition:
- New
- HazmatClass:
- Yes
- MPN:
- D-080-1ML
- DEA:
- Yes
akash.verma@cenmed.com
(732) 447-1115





